Healthcare Growth Focus Avista Healthcare Partners has a strong track record of investing over $9 billion in 50 healthcare businesses globally, indicating significant interest and expertise in scaling healthcare companies, particularly those with robust growth potential across multiple sub-sectors facing favorable market tailwinds.

Recent Portfolio Expansions The firm actively acquires and divests healthcare assets, exemplified by recent high-profile transactions including the acquisition of Trillium Health Care Products and the sale of assets to notable firms like Hamilton Lane and Novo Holdings, demonstrating ongoing opportunities for partnership and asset growth.

Strategic Industry Focus Avista’s focus on product and technology-driven healthcare businesses with stable cash flows and strong management teams presents opportunities for vendor collaborations, technology integrations, and strategic sourcing in fast-growing subsectors like medical devices and healthcare services.

Targeted Market Niche With a dedicated concentration on healthcare, especially in areas such as contract manufacturing and medical product development, there is high potential for service providers, technology vendors, and strategic partners to align with Avista’s portfolio companies' needs.

Financial and Operational Scale Operating with a revenue range of $50M to $100M and an investment scope of billions, Avista offers significant market leverage for suppliers, service providers, and technology firms looking to engage with established, high-growth healthcare entities poised for expansion.